Physiq – Medical Alley Association

Physiq

In the Know: Healthcare News for November 21, 2022

Sanford, Fairview Revive Merger Talk — a Decade After Last Attempt Failed U of M and DEED Launch Venture Capital Programs Kindeva Drug Delivery and Meridian Medical Technologies To Combine Lifecore Biomedical Announces Completion of Corporate Name Change Best Buy Invests in RPM Solution Provider Coeus h3c Genesis Medtech Unveils New Revolutionary MedTech Campus Gravie […]

Innovative Oncology CRO OncoBay Clinical Joins physIQ Intrepid Partner Program

CHICAGO, IL AND TAMPA, FL – November 15, 2022 – physIQ, a leader in continuous remote patient monitoring (cRPM) and data analytics, announced today that OncoBay Clinical, Inc., a leading oncology-focused Contract Research Organization (CRO) has joined the Intrepid™ Partner Program. OncoBay will use physIQ’s technology to monitor and evaluate the health and safety of cancer patients and treatment effectiveness in […]

In the Know: Healthcare News for March 21, 2022

Saluda Medical Announces $125M Equity Financing Led by Redmile Group LLC and New Investors Fidelity Management & Research Company LLC and T. Rowe Price Associates, Inc. Colder Products Co. Expands with Build-Out of 168,000 Square Foot Arden Hills Facility New Video Game Company Aims to Develop Therapeutic Games Minnesota Pharmaceutical Firm Launches New Drug — […]

Science 37® and PhysIQ Collaborate to Enhance Clinical Trial Data Collected from Connected Devices

Collaboration will yield objective, predictive, and real-time digital measures—supplementing clinical trial digital endpoints collected from biosensors.     RESEARCH TRIANGLE PARK, N.C., and CHICAGO, February 3rd, 2022 — Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, and physIQ Inc, a leader in digital medicine, today announced a collaboration to help research sponsors use […]

Newly Published physIQ and UI Health Study on the Efficacy of Novel COVID-19 Decompensation Index

NIH-funded DeCODe clinical study evaluates FDA-cleared AI analytics platform (pinpointIQTM) and a wearable biosensor to remotely monitor patients with COVID-19 First-in-Kind COVID-19 Decompensation Index (CDI) identifies early signs of worsening health with a lower false alarm rate compared to standard-of-care modalities Findings suggests the potential for wearable sensor-based analytics to detect exacerbation of infectious disease […]

New Executive Appointments Position physIQ for Further Strategic Growth and Market Expansion

Pharma veteran Mike Petrarca joins physIQ to drive revenue growth in the life sciences continuum; Chris Economos to advance strategic partnerships CHICAGO, IL – November 18, 2021 – Supporting the organization’s strong growth trajectory, physIQ, a leader in digital medicine, today announces the promotion and appointment of two executive officers. Chris Economos, previously chief commercial officer at physIQ, […]

Purdue University and physIQ Partner to Develop a Smartwatch-based Algorithm to Detect Early Signs of Viral Infections, Including COVID-19

Early detection of viral infections may be as easy as wearing a smartwatch physIQ app embedded in watch collects physiological data as patients are monitored remotely Collaboration advances expansion of other smartwatch-based monitoring applications WEST LAFAYETTE, Ind. – October, 28, 2021 – Purdue University and physIQ, a leader in digital medicine, announced the co-development of a viral detection algorithm for […]

physIQ Expands Leadership Team to Advance Digital Health Innovation and Strategic Global Growth

CHICAGO, Ill. – October 7, 2021 – A leader in digital medicine, physIQ today announced the hiring of Gary Manning as Senior Vice President and General Manager of Healthcare Delivery, and John Varaklis as Chief Strategy Officer. Both new hires play a critical role in the company’s expansion strategy and reflect its commitment to providing solutions […]

PhysIQ Adds NorthShore University HealthSystem to COVID-19 Digital Biomarker Study

CHICAGO, IL – June 15, 2021 – NorthShore University HealthSystem (NorthShore) has joined physIQ’s NIH-funded DeCODe study to develop an AI-based COVID-19 digital biomarker. NorthShore will serve as an enrollment center and key partner in the Phase II validation stage of this study. “Continuing NorthShore University HealthSystem’s mission to be at the forefront of innovation, we are thrilled to partner with physIQ again,” said […]

Intermountain Healthcare, UTHealth in Houston and Rush University Join PhysIQ’s Study to Develop COVID-19 Digital Biomarker

CHICAGO, IL – May 25, 2021 – Digital health leader, physIQ Inc., recently announced that Intermountain Healthcare Utah, The University of Texas Health Science Center at Houston (UTHealth) and Rush University Medical Center have joined the NIH-funded DeCODe study to develop an AI-based COVID-19 digital biomarker. These institutions will serve as recruiting centers and key partners in the Phase II validation stage of this study. Realization […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER